Laboratory Programme (Level 1: Screening Tests; Level 2 Assays)
This programme provides EQA for 30 different tests of haemostasis and thrombosis, including screening tests (e.g. PT, APTT, Thrombin time), anticoagulant control (e.g. INR, anti-Xa assays), factor assays and thrombophilia screening.
Molecular Genetics of Thrombophilia Programme
This programme provides EQA for centres testing for prothrombotic mutations FV Leiden and the Prothrombin gene mutation G20210A. EQA is also available for the C677T MTHFR gene mutation.
Genetics of Heritable Bleeding & Thrombotic Disorders Programme
This programme provides EQA for genetics centres performing analysis of samples for heritable bleeding disorders, including Haemophilia A and B, von Willebrand's disease.
Providing external quality assessment for assay of homocysteine.
DOAC (Direct Oral Anticoagulant) Assay Programme
This programme provides EQA for laboratories performing assays for the following DOACs - Dabigatran, Rivaroxaban, Apixaban.
FXIII Assay Programme
This programme is to provide external quality assessment (EQA), as part of the overall quality assurance, for FXIII assays.
ADAMTS13 Assay Programme
This programme provides EQA for laboratories performing assays for ADAMTS13, for diagnosis and treatment monitoring of TTP.
We also carry out additional exercises, on an ad-hoc basis, for other assays and for educational purposes.